azathioprine has been researched along with Arrhythmogenic Right Ventricular Dysplasia in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Arrhythmogenic Right Ventricular Dysplasia: A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peretto, G | 1 |
| Barzaghi, F | 1 |
| Cicalese, MP | 1 |
| Di Resta, C | 1 |
| Slavich, M | 1 |
| Benedetti, S | 1 |
| Giangiobbe, S | 1 |
| Rizzo, S | 1 |
| Palmisano, A | 1 |
| Esposito, A | 1 |
| De Cobelli, F | 1 |
| Gulletta, S | 1 |
| Basso, C | 1 |
| Casari, G | 1 |
| Aiuti, A | 1 |
| Della Bella, P | 1 |
| Sala, S | 1 |
1 other study available for azathioprine and Arrhythmogenic Right Ventricular Dysplasia
| Article | Year |
|---|---|
Immunosuppressive therapy in childhood-onset arrhythmogenic inflammatory cardiomyopathy.
Topics: Arrhythmogenic Right Ventricular Dysplasia; Azathioprine; Biomarkers; Child; Echocardiography; Elect | 2021 |